{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:38:21Z","timestamp":1788899901987,"version":"build-2803163510"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human papillomavirus (HPV) genotypes differ by geographic location. With the advent of HPV vaccination and HPV-based cervical screening tests in Ethiopia, a nationwide dataset on the genotype distribution of HPV among women has paramount importance in the fight against cervical cancer. However, there is limited data in this regard in the northwest part of the country. Therefore, this study aimed to identify the genotype distribution of high-risk HPVs among women presenting with cervical abnormalities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A health facility-based cross-sectional study was conducted at Felege Hiwot Comprehensive Specialized Hospital (FHCSH), Bahir Dar\u2013Ethiopia. Women aged\u2009\u2265\u200930\u00a0years who visited the hospital gynecology unit from 01 March 2019 to 30 October 2021 were included. Following general and pelvic examinations, a senior gynecologist collected cervical punch biopsies for histopathological examinations and cervical swabs for HR-HPV detection using the Abbott Alinity m system (Abbott Molecular, Des Plaines, IL, USA). Extended genotyping was carried out with the INNO-LiPA HPV Genotyping\u00a0Extra\u00a0II assay (INNO-LiPA; Fujirebio Europe, Ghent, Belgium) as per the manufacturer protocols at the Institute of Virology, Leipzig University Hospital, Germany.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 355 women with a mean age of 46.4\u2009\u00b1\u200911.4\u00a0years. The majority of the participants, 277 (79.4%) were sexually active before the age of 18\u00a0years and 180 (51.6%) had multiple sexual partners. Forty-eight (13.5%) of the participants were HIV positive. The proportion of HR-HPV was 53.0% (n\u2009=\u2009188; 95%CI: 47.8\u201358.1%). From these samples, 13 different HR-HPV types with a total of 258 sequences were identified. The detection of HR-HPV increased significantly with an increase in the age of the participants. The predominant identified HR-HPV was HPV16, 50.4% followed by HPV31 (9.7%), HPV33 (8.5%), HPV39, and HPV68 each (5.8%) and HPV18 (4.7%). Of the total HR-HPV-positive women, 23.9% (45\/188) were infected with multiple HR-HPV types. All HPV16, HPV18, HPV35, and HPV45 genotypes (as a single or in coinfections) were found to be associated with either high-grade lesions or cervical cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HR-HPV infection was reportedly higher among women in the present study area. Based on our findings, we strongly recommend the nonavalent HPV vaccine for immunization and any HPV-based screening method to take into consideration the predominant genotypes circulating in the country. The role of multiple HPV infections in high-grade cervical lesions entails further study in Ethiopia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13027-023-00481-3","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T22:04:18Z","timestamp":1674770658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["High-risk human papillomavirus genotype distribution among women with gynecology complaints in northwest Ethiopia"],"prefix":"10.1186","volume":"18","author":[{"given":"Awoke","family":"Derbie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bereket","family":"Amare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyaya","family":"Misgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endalkachew","family":"Nibret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe G.","family":"Liebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimtubezinash","family":"Woldeamanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamrat","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,27]]},"reference":[{"key":"481_CR1","unstructured":"Bruni LAG, Serrano B, Mena M, Collado JJ, G\u00f3mez D, Mu\u00f1oz J, Bosch FX, de Sanjos\u00e9 S. ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. In: Summary report 22 October 2021; 2021."},{"key":"481_CR2","unstructured":"WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem 2020. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/336583\/9789240014107-eng.pdf"},{"key":"481_CR3","unstructured":"Cancer WIAfRo. Cancer tomorrow: estimated number of cervical cancer incidence and mortality in Ethiopia 2020. https:\/\/gco.iarc.fr\/tomorrow\/en\/dataviz\/isotype?cancers=23&single_unit=500&populations=231&group_populations=1&multiple_populations=1&sexes=0&types=1&age_start=0"},{"issue":"2","key":"481_CR4","first-page":"S166","volume":"53","author":"G Santos-Lopez","year":"2015","unstructured":"Santos-Lopez G, Marquez-Dominguez L, Reyes-Leyva J, Vallejo-Ruiz V. General aspects of structure, classification and replication of human papillomavirus. Rev Med Inst Mex Seguro Soc. 2015;53(2):S166\u201371.","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"481_CR5","unstructured":"WHO. Human papillomavirus (HPV) and cervical cancer 2016. http:\/\/www.who.int\/mediacentre\/factsheets\/fs380\/en\/"},{"key":"481_CR6","unstructured":"Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, G\u00f3mez D, et al. ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 2017. 2017 http:\/\/www.hpvcentre.net\/statistics\/reports\/XWX.pdf"},{"issue":"6\u20137","key":"481_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1600-0463.2010.02625.x","volume":"118","author":"LT Chow","year":"2010","unstructured":"Chow LT, Broker TR, Steinberg BM. The natural history of human papillomavirus infections of the mucosal epithelia. APMIS. 2010;118(6\u20137):422\u201349.","journal-title":"APMIS"},{"issue":"30","key":"481_CR8","first-page":"083","volume":"20","author":"J Doorbar","year":"2012","unstructured":"Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, et al. The biology and life-cycle of human papillomaviruses. Vaccine. 2012;20(30):083.","journal-title":"Vaccine"},{"issue":"1","key":"481_CR9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/annurev-virology-100114-055021","volume":"2","author":"NA Wallace","year":"2015","unstructured":"Wallace NA, Galloway DA. Novel functions of the human papillomavirus E6 oncoproteins. Annu Rev Virol. 2015;2(1):403\u201323.","journal-title":"Annu Rev Virol"},{"key":"481_CR10","unstructured":"Centre IIICoHaCHI. Human Papillomavirus and Related Diseases Report 2017. http:\/\/www.hpvcentre.net\/statistics\/reports\/XWX.pdf"},{"issue":"21","key":"481_CR11","doi-asserted-by":"publisher","first-page":"11451","DOI":"10.1128\/JVI.78.21.11451-11460.2004","volume":"78","author":"K M\u00fcnger","year":"2004","unstructured":"M\u00fcnger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M, et al. Mechanisms of human papillomavirus-induced oncogenesis. J Virol. 2004;78(21):11451\u201360.","journal-title":"J Virol"},{"issue":"1","key":"481_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2217\/fvl.10.73","volume":"6","author":"VM Williams","year":"2011","unstructured":"Williams VM, Filippova M, Soto U, Duerksen-Hughes PJ. HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Futur Virol. 2011;6(1):45\u201357.","journal-title":"Futur Virol"},{"key":"481_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fmicb.2012.00152","volume":"3","author":"N Kajitani","year":"2012","unstructured":"Kajitani N, Satsuka A, Kawate A, Sakai H. Productive lifecycle of human papillomaviruses that depends upon squamous epithelial differentiation. Front Microbiol. 2012;3:152.","journal-title":"Front Microbiol"},{"issue":"10","key":"481_CR14","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/j.1349-7006.2007.00546.x","volume":"98","author":"M Narisawa-Saito","year":"2007","unstructured":"Narisawa-Saito M, Kiyono T. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci. 2007;98(10):1505\u201311.","journal-title":"Cancer Sci"},{"key":"481_CR15","unstructured":"WHO. Human papil-lomavirus and related cancers in world. Summary Report 2010. 2010."},{"key":"481_CR16","unstructured":"FMoH. Federal Ministry of Health: guideline for cervical cancer prevention and control in Ethiopia. 2013."},{"key":"481_CR17","unstructured":"WHO. Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland 2013."},{"key":"481_CR18","unstructured":"WHO. Cervical Cancer 2022. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer"},{"issue":"1","key":"481_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12985-022-01741-1","volume":"19","author":"A Derbie","year":"2022","unstructured":"Derbie A, Mekonnen D, Nibret E, Maier M, Woldeamanuel Y, Abebe T. Human papillomavirus genotype distribution in Ethiopia: an updated systematic review. Virol J. 2022;19(1):13.","journal-title":"Virol J"},{"key":"481_CR20","unstructured":"Health EMo. Expanded Program on Immunization (EPI) 2022. https:\/\/www.moh.gov.et\/site\/Expanded_Program_on_Immunization_%28EPI%29"},{"issue":"1","key":"481_CR21","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1038\/s41598-020-63882-z","volume":"10","author":"MB Fitzpatrick","year":"2020","unstructured":"Fitzpatrick MB, Hahn Z, Mandishora RSD, Dao J, Weber J, Huang C, et al. Whole-genome analysis of cervical human papillomavirus type 35 from rural Zimbabwean women. Sci Rep. 2020;10(1):7001.","journal-title":"Sci Rep"},{"issue":"1","key":"481_CR22","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1080\/07853890.2021.1938201","volume":"53","author":"AU Emeribe","year":"2021","unstructured":"Emeribe AU, Abdullahi IN, Etukudo MH, Isong IK, Emeribe AO, Nwofe JO, et al. The pattern of human papillomavirus infection and genotypes among Nigerian women from 1999 to 2019: a systematic review. Ann Med. 2021;53(1):944\u201359.","journal-title":"Ann Med"},{"key":"481_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1750-9378-9-33","volume":"9","author":"S-R Leyh-Bannurah","year":"2014","unstructured":"Leyh-Bannurah S-R, Prugger C, de Koning MNC, Goette H, Lell\u00e9 RJ. Cervical human papillomavirus prevalence and genotype distribution among hybrid capture 2 positive women 15 to 64 years of age in the Gurage zone, rural Ethiopia. Infect Agents Cancer. 2014;9:33.","journal-title":"Infect Agents Cancer"},{"issue":"3","key":"481_CR24","first-page":"151","volume":"43","author":"B Fanta","year":"2005","unstructured":"Fanta B. The distribution of Human Papilloma Virus infection in women with cervical histological abnormalities from an area with high incidence of cervical cancer. Ethiop Med J. 2005;43(3):151\u20138.","journal-title":"Ethiop Med J"},{"issue":"2","key":"481_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/jmv.23437","volume":"85","author":"E Abate","year":"2013","unstructured":"Abate E, Aseffa A, El-Tayeb M, El-Hassan I, Yamuah L, Mihret W, et al. Genotyping of human papillomavirus in paraffin embedded cervical tissue samples from women in ethiopia and the Sudan. J Med Virol. 2013;85(2):282\u20137.","journal-title":"J Med Virol"},{"issue":"8","key":"481_CR26","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/j.1365-3156.2010.02552.x","volume":"15","author":"A Bekele","year":"2010","unstructured":"Bekele A, Baay M, Mekonnen Z, Suleman S, Chatterjee S. Human papillomavirus type distribution among women with cervical pathology: a study over 4 years at Jimma Hospital, southwest Ethiopia. Trop Med Int Health. 2010;15(8):890\u20133.","journal-title":"Trop Med Int Health"},{"key":"481_CR27","first-page":"49","volume":"1","author":"W Mihret","year":"2014","unstructured":"Mihret W, Yusuf L, Abebe M, Yamuah LK, Bekele L, Abate E, et al. A pilot study on detection and genotyping of humanpapilloma virus isolated from clinically diagnosed Ethiopian women having cervical intraepithelial neoplasia. Ethiop Med J. 2014;1:49\u201352.","journal-title":"Ethiop Med J"},{"key":"481_CR28","volume-title":"Prevalence and genotype distribution of high risk human papilloma virus and cervical cytology abnormalities at selected obstetrics and gynecology clinics, in Addis Ababa","author":"K Eshetu","year":"2015","unstructured":"Eshetu K. Prevalence and genotype distribution of high risk human papilloma virus and cervical cytology abnormalities at selected obstetrics and gynecology clinics, in Addis Ababa. Ethiopia: Addis Ababa University; 2015."},{"issue":"9","key":"481_CR29","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10654-006-9055-4","volume":"21","author":"R Ruland","year":"2006","unstructured":"Ruland R, Prugger C, Schiffer R, Regidor M, Lell\u00e9 R. Prevalence of human papilloma virus infection in women in rural Ethiopia. Eur J Epidemiol. 2006;21(9):727\u20139.","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"481_CR30","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/ijc.33278","volume":"148","author":"B Teka","year":"2021","unstructured":"Teka B, Gizaw M, Ruddies F, Addissie A, Chanyalew Z, Skof AS, et al. Population-based human papillomavirus infection and genotype distribution among women in rural areas of South Central Ethiopia. Int J Cancer. 2021;148(3):723\u201330.","journal-title":"Int J Cancer"},{"key":"481_CR31","unstructured":"Gebremeskel TA. Molecular Epidemiology of HPV in Northern Ethiopia. 2018."},{"key":"481_CR32","unstructured":"Cancer.Net. Cervical Cancer: Symptoms and Signs 2017. https:\/\/www.cancer.net\/cancer-types\/cervical-cancer\/symptoms-and-signs"},{"key":"481_CR33","unstructured":"Health FDRoEMo. Guideline for cervical cancer prevention and control in Ethiopia 2015. https:\/\/www.iccp-portal.org\/system\/files\/plans\/Guideline%20Eth%20Final.pdf"},{"key":"481_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jcv.2018.08.010","volume":"108","author":"N Tifaoui","year":"2018","unstructured":"Tifaoui N, Maudelonde T, Combecal J, Vallo R, Doutre S, Didelot MN, et al. High-risk HPV detection and associated cervical lesions in a population of French menopausal women. J Clin Virol. 2018;108:12\u20138.","journal-title":"J Clin Virol"},{"issue":"6","key":"481_CR35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.7150\/jca.17416","volume":"8","author":"Z Wang","year":"2017","unstructured":"Wang Z, Wang J, Fan J, Zhao W, Yang X, Wu L, et al. Risk factors for cervical intraepithelial neoplasia and cervical cancer in Chinese women: large study in Jiexiu, Shanxi Province. China J Cancer. 2017;8(6):924\u201332.","journal-title":"China J Cancer"},{"issue":"4","key":"481_CR36","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3390\/nu10040469","volume":"10","author":"M Barchitta","year":"2018","unstructured":"Barchitta M, Maugeri A, Quattrocchi A, Agrifoglio O, Scalisi A, Agodi A. The association of dietary patterns with high-risk human papillomavirus infection and cervical cancer: a cross-sectional study in Italy. Nutrients. 2018;10(4):469.","journal-title":"Nutrients"},{"issue":"2","key":"481_CR37","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ygyno.2012.11.003","volume":"128","author":"P Luhn","year":"2013","unstructured":"Luhn P, Walker J, Schiffman M, Zuna RE, Dunn ST, Gold MA, et al. The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecol Oncol. 2013;128(2):265\u201370.","journal-title":"Gynecol Oncol"},{"key":"481_CR38","unstructured":"WHO. Integrated Africa Cancer Factsheet Focusing on Cervical Cancer 2014. http:\/\/www.who.int\/pmnch\/media\/events\/2014\/africa_cancer_factsheet.pdf"},{"issue":"6","key":"481_CR39","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/cid\/cix455","volume":"65","author":"LM Niccolai","year":"2017","unstructured":"Niccolai LM, Meek JI, Brackney M, Hadler JL, Sosa LE, Weinberger DM. Declines in human papillomavirus (HPV)-associated high-grade cervical lesions after introduction of HPV vaccines in Connecticut, United States, 2008\u20132015. Clin Infect Dis. 2017;65(6):884\u20139.","journal-title":"Clin Infect Dis"},{"key":"481_CR40","doi-asserted-by":"crossref","unstructured":"Kambouris M, Chini V, Daskalaki A. HPV Detection and genotyping using the Luminex xMAP Technology 2010. http:\/\/www.irma-international.org\/viewtitle\/40440\/","DOI":"10.4018\/978-1-60566-733-1.ch006"},{"issue":"6","key":"481_CR41","doi-asserted-by":"publisher","first-page":"e00286","DOI":"10.1128\/JCM.00286-21","volume":"59","author":"SK Dhillon","year":"2021","unstructured":"Dhillon SK, O\u0161trbenk Valen\u010dak A, Xu L, Poljak M, Arbyn M. Clinical and analytical evaluation of the Alinity m HR HPV assay within the VALGENT-3 framework. J Clin Microbiol. 2021;59(6):e00286-e321.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"481_CR42","doi-asserted-by":"publisher","first-page":"e01120-19","DOI":"10.1128\/JCM.01120-19","volume":"58","author":"A O\u0161trbenk Valen\u010dak","year":"2019","unstructured":"O\u0161trbenk Valen\u010dak A, \u0160terbenc A, Seme K, Poljak M. Alinity m HR HPV assay fulfills criteria for human papillomavirus test requirements in cervical cancer screening settings. J Clin Microbiol. 2019;58(1):e01120-19.","journal-title":"J Clin Microbiol."},{"key":"481_CR43","unstructured":"Abbott. ALINITY m HR HPV ASSAY 2022. https:\/\/www.molecular.abbott\/int\/en\/products\/infectious-disease\/alinity-m-hr-hpv-assay"},{"key":"481_CR44","doi-asserted-by":"publisher","first-page":"200224","DOI":"10.1016\/j.tvr.2021.200224","volume":"12","author":"D Jang","year":"2021","unstructured":"Jang D, Ratnam S, Smieja M, Speicher DJ, Arias M, Clavio A, et al. Comparison of alinity m HPV and cobas HPV assays on cervical specimens in diverse storage media. Tumour Virus Res. 2021;12:200224.","journal-title":"Tumour Virus Res"},{"key":"481_CR45","unstructured":"Abott. HR HPV AMP kit 2020. https:\/\/www.steinberg-partner.de\/files\/dr-steinberg\/dokumente\/downloads\/PI_HR%20HPV%20AMP%20Kit.pdf"},{"key":"481_CR46","unstructured":"INNO-LiPA N.VI HPV Genotyping Extra 2011. https:\/\/search.cosmobio.co.jp\/cosmo_search_p\/search_gate2\/docs\/IGT_\/8106381064.20130815.pdf"},{"issue":"7","key":"481_CR47","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/jop.13172","volume":"50","author":"P Tewari","year":"2021","unstructured":"Tewari P, Banka P, Kernan N, Reynolds S, White C, Pilkington L, et al. Prevalence and concordance of oral HPV infections with cervical HPV infections in women referred to colposcopy with abnormal cytology. J Oral Pathol Med. 2021;50(7):692\u20139.","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"481_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12905-017-0444-5","volume":"17","author":"G Ameya","year":"2017","unstructured":"Ameya G, Yerakly F. Characteristics of cervical disease among symptomatic women with histopathological sample at Hawassa University referral hospital, Southern Ethiopia. BMC Womens Health. 2017;17(1):91.","journal-title":"BMC Womens Health"},{"issue":"6","key":"481_CR49","doi-asserted-by":"publisher","first-page":"e0157432","DOI":"10.1371\/journal.pone.0157432","volume":"11","author":"M Ardhaoui","year":"2016","unstructured":"Ardhaoui M, Ennaifer E, Letaief H, Salsabil R, Lassili T, Chahed K, et al. Prevalence, genotype distribution and risk factors for cervical human papillomavirus infection in the Grand Tunis Region, Tunisia. PLoS ONE. 2016;11(6):e0157432.","journal-title":"PLoS ONE"},{"issue":"28","key":"481_CR50","first-page":"018","volume":"13","author":"D Wolday","year":"2018","unstructured":"Wolday D, Derese M, Gebressellassie S, Tsegaye B, Ergete W, Gebrehiwot Y, et al. HPV genotype distribution among women with normal and abnormal cervical cytology presenting in a tertiary gynecology referral Clinic in Ethiopia. Infect Agent Cancer. 2018;13(28):018\u20130201.","journal-title":"Infect Agent Cancer"},{"issue":"1","key":"481_CR51","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12879-021-05956-5","volume":"21","author":"AP Kuassi-Kpede","year":"2021","unstructured":"Kuassi-Kpede AP, Dolou E, Zohoncon TM, Traore IMA, Katawa G, Ouedraogo RA, et al. Molecular characterization of high-risk human papillomavirus (HR-HPV) in women in Lom\u00e9, Togo. BMC Infect Dis. 2021;21(1):278.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"481_CR52","doi-asserted-by":"publisher","first-page":"e0257324","DOI":"10.1371\/journal.pone.0257324","volume":"16","author":"O Kuguyo","year":"2021","unstructured":"Kuguyo O, Dube Mandishora RS, Thomford NE, Makunike-Mutasa R, Nhachi CFB, Matimba A, et al. High-risk HPV genotypes in Zimbabwean women with cervical cancer: comparative analyses between HIV-negative and HIV-positive women. PLoS ONE. 2021;16(9):e0257324.","journal-title":"PLoS ONE"},{"issue":"2","key":"481_CR53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/0956462419884454","volume":"31","author":"K Sweet","year":"2020","unstructured":"Sweet K, Bosire C, Sanusi B, Sherrod CJ, Kwatampora J, Waweru W, et al. Prevalence, incidence, and distribution of human papillomavirus types in female sex workers in Kenya. Int J STD AIDS. 2020;31(2):109\u201318.","journal-title":"Int J STD AIDS"},{"key":"481_CR54","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1200\/GO.21.00151","volume":"7","author":"P Jeudin","year":"2021","unstructured":"Jeudin P, Abebe T, Butler R, Hooi D, Watt A, Capo-Chichi CD, et al. Human papilloma virus distribution across the African diaspora. JCO Glob Oncol. 2021;7:1206\u20138.","journal-title":"JCO Glob Oncol"},{"issue":"9","key":"481_CR55","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3855\/jidc.15218","volume":"15","author":"R Tagne Simo","year":"2021","unstructured":"Tagne Simo R, Djoko Nono AG, Fogang Dongmo HP, Seke Etet PF, Fonyuy BK, Kamdje AHN, et al. Prevalence of precancerous cervical lesions and high-risk human papillomavirus types in Yaounde. Cameroon J Infect Dev Ctries. 2021;15(9):1339\u201345.","journal-title":"Cameroon J Infect Dev Ctries"},{"issue":"4","key":"481_CR56","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.4314\/ahs.v21i4.27","volume":"21","author":"E Dolou","year":"2021","unstructured":"Dolou E, Kuassi-Kpede A, Zohoncon TM, Traore IM, Katawa G, Ouedraogo AR, et al. Molecular characterization of high-risk human papillomavirus genotypes in women with or without cervical lesions at VIA\/VILI in Kara. Togo African Health Sci. 2021;21(4):1715\u201321.","journal-title":"Togo African Health Sci"},{"issue":"4","key":"481_CR57","doi-asserted-by":"publisher","first-page":"e122488","DOI":"10.1371\/journal.pone.0122488","volume":"10","author":"RK Ogembo","year":"2015","unstructured":"Ogembo RK, Gona PN, Seymour AJ, Park HS, Bain PA, Maranda L, et al. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis. PLoS One. 2015;10(4):e122488.","journal-title":"PLoS One."},{"issue":"2","key":"481_CR58","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1071\/SH11066","volume":"9","author":"RR Peng","year":"2012","unstructured":"Peng RR, Li HM, Chang H, Li JH, Wang AL, Chen XS. Prevalence and genotype distribution of cervical human papillomavirus infection among female sex workers in Asia: a systematic literature review and meta-analysis. Sex Health. 2012;9(2):113\u20139.","journal-title":"Sex Health"},{"issue":"5","key":"481_CR59","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-04-0812","volume":"14","author":"GM Clifford","year":"2005","unstructured":"Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(5):1157\u201364.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"481_CR60","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1371\/journal.pone.0025493","volume":"6","author":"A Ciapponi","year":"2011","unstructured":"Ciapponi A, Bardach A, Glujovsky D, Gibbons L, Picconi MA. Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis. PLoS ONE. 2011;6(10):4.","journal-title":"PLoS ONE"},{"issue":"1","key":"481_CR61","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1471-2334-9-124","volume":"9","author":"P Conesa-Zamora","year":"2009","unstructured":"Conesa-Zamora P, Ortiz-Reina S, Moya-Biosca J, Dom\u00e9nech-Peris A, Orantes-Casado FJ, P\u00e9rez-Guillermo M, et al. Genotype distribution of human papillomavirus (HPV) and co-infections in cervical cytologic specimens from two outpatient gynecological clinics in a region of southeast Spain. BMC Infect Dis. 2009;9(1):124.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"481_CR62","first-page":"222","volume":"158","author":"B Gonz\u00e1lez-Yebra","year":"2022","unstructured":"Gonz\u00e1lez-Yebra B, Mojica-Larrea M, Alonso R, Gonz\u00e1lez AL, Romero-Morelos P, Taniguchi-Ponciano K, et al. HPV infection profile in cervical lesions. Gac Med Mex. 2022;158(4):222\u20138.","journal-title":"Gac Med Mex"},{"issue":"4","key":"481_CR63","first-page":"236","volume":"85","author":"B Sehnal","year":"2020","unstructured":"Sehnal B, Sl\u00e1ma J. What next in cervical cancer screening? Ceska Gynekol. 2020;85(4):236\u201343.","journal-title":"Ceska Gynekol"},{"key":"481_CR64","first-page":"2020","volume-title":"Global strategy to accelerate the elimination of cervical cancer as a public health problem","author":"World Health O","year":"2020","unstructured":"World Health O. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization; 2020. p. 2020."},{"key":"481_CR65","doi-asserted-by":"crossref","unstructured":"Wondimu A, Postma MJ, van Hulst M. Cost-effectiveness analysis of quadrivalent and nonavalent human papillomavirus vaccines in Ethiopia. Vaccine. 2022.","DOI":"10.1016\/j.vaccine.2022.02.080"},{"issue":"4","key":"481_CR66","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/jmv.21429","volume":"81","author":"BD Bello","year":"2009","unstructured":"Bello BD, Spinillo A, Alberizzi P, Cesari S, Gardella B, D\u2019Ambrosio G, et al. Cervical infections by multiple human papillomavirus (HPV) genotypes: prevalence and impact on the risk of precancerous epithelial lesions. J Med Virol. 2009;81(4):703\u201312.","journal-title":"J Med Virol"},{"key":"481_CR67","doi-asserted-by":"publisher","first-page":"12583","DOI":"10.2147\/CMAR.S269050","volume":"12","author":"L Song","year":"2020","unstructured":"Song L, Lyu Y, Ding L, Li X, Gao W, Wang M, et al. Prevalence and genotype distribution of high-risk human papillomavirus infection in women with abnormal cervical cytology: a population-based study in Shanxi Province. China Cancer Manag Res. 2020;12:12583\u201391.","journal-title":"China Cancer Manag Res"},{"issue":"9","key":"481_CR68","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1002\/ijc.24528","volume":"125","author":"N Wentzensen","year":"2009","unstructured":"Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, Allen RA, et al. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer. 2009;125(9):2151\u20138.","journal-title":"Int J Cancer"},{"issue":"11","key":"481_CR69","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1158\/1055-9965.EPI-19-0239","volume":"28","author":"R Adcock","year":"2019","unstructured":"Adcock R, Cuzick J, Hunt WC, McDonald RM, Wheeler CM. Role of HPV Genotype, Multiple Infections, and Viral Load on the Risk of High-Grade Cervical Neoplasia. Cancer Epidemiol Biomark Prevent. 2019;28(11):1816\u201324.","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"7","key":"481_CR70","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.3390\/v13071342","volume":"13","author":"M Kim","year":"2021","unstructured":"Kim M, Park NJ-Y, Jeong JY, Park JY. Multiple human papilloma virus (HPV) infections are associated with HSIL and persistent HPV infection status in Korean patients. Viruses. 2021;13(7):1342.","journal-title":"Viruses"},{"issue":"3","key":"481_CR71","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s13337-019-00545-2","volume":"30","author":"N Joharinia","year":"2019","unstructured":"Joharinia N, Farhadi A, Hosseini SY, Safaei A, Sarvari J. Association of HPV16 and 18 genomic copies with histological grades of cervical lesions. Virusdisease. 2019;30(3):387\u201393.","journal-title":"Virusdisease"},{"issue":"2","key":"481_CR72","first-page":"107","volume":"10","author":"W Tjalma","year":"2018","unstructured":"Tjalma W. HPV negative cervical cancers and primary HPV screening. Facts Views Vis Obgyn. 2018;10(2):107\u201313.","journal-title":"Facts Views Vis Obgyn"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-023-00481-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-023-00481-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-023-00481-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T10:06:17Z","timestamp":1674900377000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-023-00481-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,27]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["481"],"URL":"https:\/\/doi.org\/10.1186\/s13027-023-00481-3","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,27]]},"assertion":[{"value":"11 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the institutional review board (IRB) of the College of Health Sciences, Addis Ababa University (Protocol number: 087\/19\/DMIP) and by the Ethiopian National Research Ethics\u00a0Review\u00a0Committee at the Ministry of\u00a0Education (Ref number: 7\/2-149\/m259\/35). Written informed consent was ensured from all study participants to take part in the study voluntarily after they get informed about the objective and purpose of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}